BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38136993)

  • 41. Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.
    Refenes N; Bolbrinker J; Tagaris G; Orlacchio A; Drakoulis N; Kreutz R
    BMC Neurol; 2009 Jun; 9():26. PubMed ID: 19558713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Excess of singleton loss-of-function variants in Parkinson's disease contributes to genetic risk.
    Bobbili DR; Banda P; Krüger R; May P
    J Med Genet; 2020 Sep; 57(9):617-623. PubMed ID: 32054687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between ABCA7 gene polymorphisms and Parkinson's disease susceptibility in a northern Chinese Han population.
    Yang Z; Xue L; Li C; Li M; Xie A
    Neurosci Lett; 2022 Jul; 784():136734. PubMed ID: 35709878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of PGLYRP2 gene polymorphism and sporadic Parkinson's disease in northern Chinese Han population.
    Luan M; Jin J; Wang Y; Li X; Xie A
    Neurosci Lett; 2022 Apr; 775():136547. PubMed ID: 35218888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.
    Tobin JE; Latourelle JC; Lew MF; Klein C; Suchowersky O; Shill HA; Golbe LI; Mark MH; Growdon JH; Wooten GF; Racette BA; Perlmutter JS; Watts R; Guttman M; Baker KB; Goldwurm S; Pezzoli G; Singer C; Saint-Hilaire MH; Hendricks AE; Williamson S; Nagle MW; Wilk JB; Massood T; Laramie JM; DeStefano AL; Litvan I; Nicholson G; Corbett A; Isaacson S; Burn DJ; Chinnery PF; Pramstaller PP; Sherman S; Al-hinti J; Drasby E; Nance M; Moller AT; Ostergaard K; Roxburgh R; Snow B; Slevin JT; Cambi F; Gusella JF; Myers RH
    Neurology; 2008 Jul; 71(1):28-34. PubMed ID: 18509094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of sixteen novel candidate genes for late onset Parkinson's disease.
    Gialluisi A; Reccia MG; Modugno N; Nutile T; Lombardi A; Di Giovannantonio LG; Pietracupa S; Ruggiero D; Scala S; Gambardella S; ; Iacoviello L; Gianfrancesco F; Acampora D; D'Esposito M; Simeone A; Ciullo M; Esposito T
    Mol Neurodegener; 2021 Jun; 16(1):35. PubMed ID: 34148545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Association analysis of the parkin gene in patients with sporadic Parkinson's disease from a Han population of Sichuan province].
    Peng R; Chen WJ; Wu Y; Liu M; Lai XH; Zhang JH; Yuan GG; Gou YR; Li T; Wang YC
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):38-41. PubMed ID: 17285542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic association of cyclooxygenase-2 gene polymorphisms with Parkinson's disease susceptibility in Chinese Han population.
    Dai Y; Wu Y; Li Y
    Int J Clin Exp Pathol; 2015; 8(10):13495-9. PubMed ID: 26722563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.
    Winkler S; König IR; Lohmann-Hedrich K; Vieregge P; Kostic V; Klein C
    Eur J Hum Genet; 2007 Nov; 15(11):1163-8. PubMed ID: 17637803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tau haplotypes regulate transcription and are associated with Parkinson's disease.
    Kwok JB; Teber ET; Loy C; Hallupp M; Nicholson G; Mellick GD; Buchanan DD; Silburn PA; Schofield PR
    Ann Neurol; 2004 Mar; 55(3):329-34. PubMed ID: 14991810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autophagy ATG16L1 rs2241880 impacts the colorectal cancer risk: A case-control study.
    Jamali L; Sadeghi H; Ghasemi MR; Mohseni R; Nazemalhosseini-Mojarad E; Yassaee VR; Larki P; Zali MR; Mirfakhraie R
    J Clin Lab Anal; 2022 Jan; 36(1):e24169. PubMed ID: 34894411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin-18 promoter polymorphisms and risk of Parkinson's disease in a Han Chinese population.
    Xu X; Li D; He Q; Gao J; Chen B; Xie A
    Brain Res; 2011 Mar; 1381():90-4. PubMed ID: 21241672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts.
    Fung HC; Xiromerisiou G; Gibbs JR; Wu YR; Eerola J; Gourbali V; Hellström O; Chen CM; Duckworth J; Papadimitriou A; Tienari PJ; Hadjigeorgiou GM; Hardy J; Singleton AB
    Neurodegener Dis; 2006; 3(6):327-33. PubMed ID: 17192721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. alpha-Synuclein and Parkinson disease susceptibility.
    Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
    Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor necrosis factor-alpha promoter polymorphism is associated with the risk of Parkinson's disease.
    Wu YR; Feng IH; Lyu RK; Chang KH; Lin YY; Chan H; Hu FJ; Lee-Chen GJ; Chen CM
    Am J Med Genet B Neuropsychiatr Genet; 2007 Apr; 144B(3):300-4. PubMed ID: 17192953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PARK16 polymorphisms, interaction with smoking, and sporadic Parkinson's disease in Japan.
    Miyake Y; Tanaka K; Fukushima W; Kiyohara C; Sasaki S; Tsuboi Y; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M; Nakamura Y;
    J Neurol Sci; 2016 Mar; 362():47-52. PubMed ID: 26944116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder.
    Li J; Ruskey JA; Arnulf I; Dauvilliers Y; Hu MTM; Högl B; Leblond CS; Zhou S; Ambalavanan A; Ross JP; Bourassa CV; Spiegelman D; Laurent SB; Stefani A; Charley Monaca C; Cochen De Cock V; Boivin M; Ferini-Strambi L; Plazzi G; Antelmi E; Young P; Heidbreder A; Labbe C; Ferman TJ; Dion PA; Fan D; Desautels A; Gagnon JF; Dupré N; Fon EA; Montplaisir JY; Boeve BF; Postuma RB; Rouleau GA; Ross OA; Gan-Or Z
    Mov Disord; 2018 Jul; 33(6):1016-1020. PubMed ID: 29756641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight.
    Bandres-Ciga S; Ahmed S; Sabir MS; Blauwendraat C; Adarmes-Gómez AD; Bernal-Bernal I; Bonilla-Toribio M; Buiza-Rueda D; Carrillo F; Carrión-Claro M; Gómez-Garre P; Jesús S; Labrador-Espinosa MA; Macias D; Méndez-Del-Barrio C; Periñán-Tocino T; Tejera-Parrado C; Vargas-González L; Diez-Fairen M; Alvarez I; Tartari JP; Buongiorno M; Aguilar M; Gorostidi A; Bergareche JA; Mondragon E; Vinagre-Aragon A; Croitoru I; Ruiz-Martínez J; Dols-Icardo O; Kulisevsky J; Marín-Lahoz J; Pagonabarraga J; Pascual-Sedano B; Ezquerra M; Cámara A; Compta Y; Fernández M; Fernández-Santiago R; Muñoz E; Tolosa E; Valldeoriola F; Gonzalez-Aramburu I; Sanchez Rodriguez A; Sierra M; Menéndez-González M; Blazquez M; Garcia C; Suarez-San Martin E; García-Ruiz P; Martínez-Castrillo JC; Vela-Desojo L; Ruz C; Barrero FJ; Escamilla-Sevilla F; Mínguez-Castellanos A; Cerdan D; Tabernero C; Gomez Heredia MJ; Perez Errazquin F; Romero-Acebal M; Feliz C; Lopez-Sendon JL; Mata M; Martínez Torres I; Kim JJ; Dalgard CL; ; Brooks J; Saez-Atienzar S; Gibbs JR; Jorda R; Botia JA; Bonet-Ponce L; Morrison KE; Clarke C; Tan M; Morris H; Edsall C; Hernandez D; Simon-Sanchez J; Nalls MA; Scholz SW; Jimenez-Escrig A; Duarte J; Vives F; Duran R; Hoenicka J; Alvarez V; Infante J; Marti MJ; Clarimón J; López de Munain A; Pastor P; Mir P; Singleton A;
    Mov Disord; 2019 Dec; 34(12):1851-1863. PubMed ID: 31660654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson's disease: a two-cohort case-control study.
    Pan HX; Zhao YW; Mei JP; Fang ZH; Wang Y; Zhou X; Zhou YJ; Zhang R; Zhang KL; Jiang L; Zeng Q; He Y; Wang Z; Liu ZH; Xu Q; Sun QY; Yang Y; Hu YC; Chen YS; Du J; Lei LF; Zhang HN; Wang CY; Yan XX; Shen L; Jiang H; Tan JQ; Li JC; Tang BS; Guo JF
    Transl Neurodegener; 2020 Aug; 9(1):31. PubMed ID: 32746945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.